Compare Stocks → Move Your Money Before May 22 (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ISRNASDAQ:NVNONASDAQ:PLSENASDAQ:TMDI Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRIsoray$0.37$0.19▼$0.45$54.57M1.48290,697 shs145,000 shsNVNOenVVeno Medical$5.27+0.8%$5.55$2.51▼$6.97$70.20M1.17116,398 shs20,047 shsPLSEPulse Biosciences$7.08+5.8%$8.74$3.78▼$13.62$390.96M1.67179,282 shs39,950 shsTMDITitan Medical$0.14-26.3%$0.23$0.13▼$1.20$15.67M2.364.83 million shs7.71 million shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRIsoray0.00%0.00%0.00%0.00%0.00%NVNOenVVeno Medical+0.19%+9.41%-4.21%+24.52%+34.10%PLSEPulse Biosciences-2.48%-9.10%-18.91%-21.48%+14.75%TMDITitan Medical0.00%0.00%0.00%0.00%0.00%Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationISRIsorayN/AN/AN/AN/AN/AN/AN/AN/ANVNOenVVeno Medical0.1986 of 5 stars0.01.00.00.02.61.70.6PLSEPulse BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ATMDITitan MedicalN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRIsorayN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/APLSEPulse BiosciencesN/AN/AN/AN/ATMDITitan MedicalN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRIsoray$10.80M0.00N/AN/A$0.43 per share0.00NVNOenVVeno MedicalN/AN/AN/AN/A$3.47 per shareN/APLSEPulse Biosciences$700K558.51N/AN/A$0.81 per share8.74TMDITitan Medical$20.09M0.78N/AN/A$0.32 per share0.44Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRIsoray-$7.27M-$0.07N/AN/AN/A-115.91%-17.12%-16.15%N/ANVNOenVVeno Medical-$23.52M-$1.92N/AN/AN/AN/A-70.17%-64.68%5/6/2024 (Estimated)PLSEPulse Biosciences-$42.21M-$0.89N/A∞N/AN/A-112.74%-61.09%5/7/2024 (Confirmed)TMDITitan Medical-$14.86M-$0.19N/A∞N/AN/A-167.03%-112.15%N/ALatest PLSE, TMDI, ISR, and NVNO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2024N/APLSEPulse BiosciencesN/AN/AN/AN/AN/AN/A 3/28/2024Q4 2023PLSEPulse BiosciencesN/A-$0.21-$0.21-$0.20N/AN/A2/29/2024Q4 2023NVNOenVVeno MedicalN/A-$0.32-$0.32-$0.32N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISRIsorayN/AN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/AN/APLSEPulse BiosciencesN/AN/AN/AN/AN/ATMDITitan MedicalN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRIsorayN/A14.3813.99NVNOenVVeno MedicalN/A34.2234.23PLSEPulse BiosciencesN/A6.766.76TMDITitan MedicalN/A1.411.41OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRIsoray11.32%NVNOenVVeno Medical34.71%PLSEPulse Biosciences76.95%TMDITitan Medical3.55%Insider OwnershipCompanyInsider OwnershipISRIsoray2.42%NVNOenVVeno Medical17.00%PLSEPulse Biosciences69.70%TMDITitan Medical0.02%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableISRIsorayN/A142.11 million138.67 millionNot OptionableNVNOenVVeno Medical1913.32 million11.05 millionOptionablePLSEPulse Biosciences6155.22 million16.73 millionOptionableTMDITitan Medical49111.95 million111.93 millionNot OptionablePLSE, TMDI, ISR, and NVNO HeadlinesSourceHeadlineTMD:CA Titan Medical Inc.seekingalpha.com - April 21 at 9:46 AMTitan Medical Inc.: Titan Medical Reports Fiscal Year 2023 Resultsfinanznachrichten.de - April 1 at 8:49 AMTitan Medical signs deal to merge with Conavi Medicalmsn.com - March 21 at 4:35 AMTitan Medical Inc TMDIFmorningstar.com - February 27 at 7:19 PMPerifery appoints Titan Data Solutions as authorised distributoradvanced-television.com - February 13 at 8:31 AMTitan Medical Inc (TMD)investing.com - February 13 at 1:56 AMVantage Titan 3T MRI Scanner from Toshibanews-medical.net - January 11 at 8:10 AMAttack on Titan: Hajime Isayama Will Create New Titan Story in 2024comicbook.com - October 3 at 1:41 AMFive dead on Titan sub were 'true explorers' - OceanGatebbc.com - September 28 at 10:21 PMTMDIF Titan Medical Inc.seekingalpha.com - August 1 at 7:27 PMFalse claim Titan passenger was the vice chairman of the World Economic Forum | Fact checkusatoday.com - July 25 at 1:09 PMNew details emerge about discovery of Titan submersible debrisen.as.com - July 19 at 9:22 AMDestiny 2 best Titan build for PvE and PvPvideogamer.com - July 18 at 7:32 AMPresumed human remains found in Titan sub debrisbbc.co.uk - July 14 at 5:59 PMThe Titan submersible imploded, killing all 5 on boardasahi.com - July 9 at 10:09 AMDebris and 'Presumed Human Remains' Recovered From Titan Submersiblemsn.com - June 30 at 7:39 PMUS Coast Guard says 'presumed human remains' found in wreckage of Titan submersiblewbaltv.com - June 30 at 1:27 PMTitan Sub Tragedy: "Presumed Human Remains" and Mangled Debris Recovered From Atlantic Oceaneonline.com - June 29 at 9:37 AMPossible human remains recovered from Titan wreckage, Coast Guard saysmsn.com - June 28 at 11:36 PMTitan submersible tragedy could lead to lawsuits and regulatory changes, experts sayyahoo.com - June 24 at 12:27 PMWhat happens during a catastrophic implosion? Titan submersible occupants likely died instantlywinknews.com - June 24 at 1:01 AMThe science that put the Titan submersible at risk of implosionktbs.com - June 24 at 1:01 AMThe Titan submersible: What could have gone wrong?msn.com - June 21 at 2:23 PMReport: Banging sounds heard during Titan submersible search, according to internal memowlox.com - June 21 at 12:43 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioStock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a monthApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a monthCaterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesApril 25, 2024 10:36 AMView Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesIntuitive Surgical Leads the Robotic Surgery MovementApril 22, 2024 6:10 AMView Intuitive Surgical Leads the Robotic Surgery MovementBuckle Up or Bail Out? The Self-Driving Taxi Market's Risky RideApril 16, 2024 9:45 AMView Buckle Up or Bail Out? The Self-Driving Taxi Market's Risky RideAll Headlines Company DescriptionsIsorayNYSE:ISRIsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.enVVeno MedicalNASDAQ:NVNOenVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial. Pulse BiosciencesNASDAQ:PLSEPulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.Titan MedicalNASDAQ:TMDITitan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.